Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Depreciation & Amortization - Total (2018)

Surgery Partners' Depreciation & Amortization - Total history spans 1 years, with the latest figure at $38.4 million for Q4 2018.

  • For Q4 2018, Depreciation & Amortization - Total changed N/A year-over-year to $38.4 million; the TTM value through Sep 2019 reached $38.4 million, changed N/A, while the annual FY2025 figure was $170.2 million, 17.54% up from the prior year.
  • Depreciation & Amortization - Total for Q4 2018 was $38.4 million at Surgery Partners.
  • Across five years, Depreciation & Amortization - Total topped out at $38.4 million in Q4 2018 and bottomed at $38.4 million in Q4 2018.